RE: Herald article6 Dec 2018 12:49
Thanks for your thoughtd unvrkw. Yes I agree its certainly not universally negative and we are in an exceptionally unforgiving market.
I've always seen CD4 commercialisation not just as the panacea (as it maybe now) but the transforming solution here.
However, the new advanced CD4 is now seen as the better solution and this, in respect of product development, has delayed the timeline for commercialisation considerably, if we assume that it will be by far the bigger seller. That is off putting to investment atm.